| Literature DB >> 26217622 |
Shin-Seok Yang1, Young-Wook Kim2, Yang Jin Park2, Dong-Ik Kim2, Shin-Young Woo2, Seung Huh3, Hyung-Kee Kim3.
Abstract
PURPOSE: The aim of study was to review the results of open surgical repair (OSR) of chronic juxtarenal aortic occlusion (JRAO).Entities:
Keywords: Juxtarenal aortic occlusion; Renal complication; Renal ischemic time; Surgical results
Year: 2014 PMID: 26217622 PMCID: PMC4480295 DOI: 10.5758/vsi.2014.30.3.81
Source DB: PubMed Journal: Vasc Specialist Int ISSN: 2288-7970
Fig. 1.Surgical photograms showing surgical procedures for a patient with juxtarenal aortic occlusion. (A) Resection of a segment of occluded infrarenal aorta without suprarenal aortic clamping. (B) Removal of thrombotic cap under the suprarenal aortic clamp, with both renal arteries controlled. (C) Transfer suprarenal aortic clamping to the infrarenal aorta allowing renal perfusion. (D) Standard aorto-femoral bypass under the infrarenal aortic clamping.
Fig. 2.Schematic drawing of the surgical reconstruction of the juxtarenal aortic occlusion to minimize renal ischemic time. (A) Segmental excision of the occluded infrarenal aortic segment (3 cm in length) without supra-renal aortic clamping. (B) Vertical aortotomy under the supra-renal aortic cross clamping and bilateral renal artery control (left renal vein division may be required during this procedure). (C) Pararenal aortic thromboendarterectomyor renal ostialendarterectomy (if required) through the vertical aortotomy. (D) Proximal aortic anastomosis after vertical aortotomy closure after moving the aortic clamp to the infrarenal aorta.
Demographics and clinical features of patients with chronic juxtarenal aortic occlusion
| Feature (n=47) | Data |
|---|---|
| Age (y) | |
| Mean±SD | 59.9±9.3 |
| Median (range) | 59 (44–79) |
| Male, n (%) | 43 (92) |
| Clinical, n (%) | |
| Leg claudication | 22 (50) |
| Rest pain | 4 (9) |
| Ischemic tissue loss | 7 (16) |
| Coexisting risk or morbidities, n (%) | |
| Smoking | 31 (66) |
| Coronary artery disease | 14 (30) |
| Cerebrovascular disease | 9 (19) |
| Chronic obstructive pulmonary disease | 3 (6) |
| Hypertension | 23 (49) |
| Diabetes mellitus | 13 (28) |
| Chronic kidney disease | 4 (9) |
| Preoperative serum creatinine (mg/dL) | |
| Mean±SD (range) | 1.0±0.6 (0.3–4.0) |
SD, standard deviation.
Smoking, currently or quit smoking <1 year ago; Hypertension, diastolic blood pressure >90 mmHg on at least two occasions or currently taking antihypertensive medication; Diabetes mellitus, history of diabetes diagnosed or fasting blood glucose >126 mg/dL; Chronic kidney disease, serum creatinine ≥2.0 mg/dL, on dialysis, or history of kidney transplantation; Coronary artery disease, history of myocardial infarction or coronary intervention or coronary artery bypass grafting.
Operative procedures
| Procedure (n=47) | Number (%) |
|---|---|
| Aortic reconstruction | |
| Aorto-biiliac | 8 (17) |
| Aorto-bifemoral | 37 (79) |
| Aorto-uniiliac and unifemoral | 1 (2) |
| Aorto-unifemoral and unipopliteal | 1 (2) |
| Aortic crossclamping site | |
| Supra-celiac | 1 (2) |
| Supra-renal | 42 (89) |
| Inter-renal | 4 (9) |
| Graft material | |
| Dacron graft | 26 (55) |
| Polytetrafluoroethylene graft | 21 (45) |
| Renal protective measure | |
| 12.5% mannitol infusion | 30 (64) |
| Furosemide infusion | 5 (11) |
| Cold saline perfusion into renal artery | 1 (2) |
| Adjuvant procedure | |
| Vertical aortotomy | 6 (13) |
| Renal artery reconstruction | 8 (17) |
| Aorto-renal bypass | 3 (6) |
| Unilateral | 2 (4) |
| Bilateral | 1 (2) |
| Renal artery orifice endarterectomy | 5 (11) |
| Unilateral | 1 (2) |
| Bilateral | 4 (9) |
| Mesenteric artery reconstruction | 3 (7) |
| Aorto-mesenteric bypass | 2 (4) |
| Inferior mesenteric artery | 1 (2) |
| Superior mesenteric artery | 1 (2) |
| Reimplantation | 1 (2) |
| Inferior mesenteric | 1 (2) |
| Femoral artery | 6 (13) |
| Patch angioplasty | 1 (2) |
| Endarterectomy | 6 (13) |
| Unilateral | 4 (9) |
| Bilateral | 2 (4) |
| Renal ischemic time (n=34 | |
| Minutes, mean±SD (range) | 10.7±5.5 (3–25) |
SD, standard deviation.
Data for renal ischemic time were available in 34 patients.
Early postoperative morbidity and mortality (within 30 days after surgery)
| Morbidity and mortality (n=47) | No. of patients (%) |
|---|---|
| Renal | |
| Postoperative renal insufficiency | 5 (11) |
| New hemodialysis | 0 (0) |
| Pulmonary | |
| Pneumonia | 1 (2) |
| Pleural effusion | 2 (4) |
| Atelectasis | 1 (2) |
| Cardiac | |
| Myocardial infarction | 1 (2) |
| Operative mortality | 0 (0) |
Postoperative renal insufficiency (postoperative serum creatinine increase to >150% from preoperative level).
Risk factor analysis for postoperative renal insufficiency (PORI) after open surgical repair of juxtarenal aortic occlusion
| Factor | Number (%) | Patients with PORI | |
|---|---|---|---|
|
| |||
| n | P-value | ||
| Age (≥75 y) | 6 (13) | 1 | 0.511 |
| Diabetes mellitus | 13 (28) | 2 | 0.607 |
| Chronic kidney disease | 4 (9) | 0 | 0.999 |
| No renal protective measure | 16 (34) | 1 | 0.648 |
| Renal artery reconstruction | 8 (17) | 1 | 0.999 |
| RIT ≥15 minutes | 10 (29) | 2 | 0.618 |
RIT, renal ischemic time.
Fisher’s exact test.
Data for renal ischemic time were available in 34 patients.
Fig. 3.Cumulative survival of patients after open surgical repair of juxtarenal aortic occlusion.